Everything below concerns deamidation. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Water is a central factor in peptide degradation because it enables hydrolysis and mobilizes reactive species. Lyophilized or dry powders typically remain stable for longer than solutions when kept cool and dry. Oxygen can drive oxidation, particularly for sulfur-containing residues, while light can catalyze side-chain damage. Buffer choice and pH influence charge state and can accelerate or slow deamidation and aggregation. Freeze-thaw cycles may concentrate solutes or promote ice-induced aggregation, so minimizing such cycles is a common handling goal.
Lyophilization removes water under vacuum from a frozen solution, leaving a porous cake or powder. Formulation excipients such as sugars or polyols can stabilize structure during freezing and drying and can raise the glass transition temperature. Residual moisture in the final product remains a critical variable because even small amounts can support hydrolysis over time. Storage recommendations often specify desiccation, darkness, and low temperature, though exact conditions depend on the peptide and its intended use. Stability studies measure changes under defined conditions rather than predicting absolute shelf life.
After reconstitution, solutions are divided into single-use aliquots and stored at -80°C. Labels include peptide name, concentration, buffer composition, date, and lot number. Freeze-thaw cycles are minimized by thawing only the needed aliquot on ice or at room temperature. Some peptides benefit from the addition of a carrier protein, such as bovine serum albumin, or a cryoprotectant like glycerol to reduce adsorption to plastic. Glass vials with low-binding surfaces are preferred for dilute solutions. Shipping of frozen aliquots uses dry ice and insulated containers to maintain the cold chain.
Receiving a peptide shipment requires immediate inspection of the packaging and temperature indicators. Any deviation from the specified cold chain should be documented and investigated. Upon arrival, solid peptides are generally kept at -20°C, whereas liquid formulations are stored at -80°C. Vials should be kept upright and protected from light. Repeated warming and cooling of the entire container is avoided by preparing smaller working aliquots. A log of lot numbers, receipt dates, and storage locations supports traceability and quality control.
Reconstitution is a critical handling step. The appropriate solvent—often sterile water, phosphate-buffered saline, or a water-acetonitrile mixture—is chosen based on peptide solubility. Adding solvent gently down the vial wall and swirling, rather than vortexing, reduces foaming and shear stress. The resulting solution should be clear; visible particles indicate incomplete dissolution or contamination. Concentration is recorded accurately because it affects subsequent use. If the peptide is not fully soluble, a small amount of organic solvent or a different buffer may be required, but this changes the final composition.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for lyophilized or dry peptide material |
| Solubility class | Often freely soluble in water | Depends on sequence and counterion |
| Typical dry storage temperature | -20 °C or lower | Cooler conditions generally slow degradation |
| Common degradation route | Hydrolysis, oxidation, deamidation | Relative importance varies by sequence |
| Typical analytical method | RP-HPLC and LC-MS | Used to assess purity and mass |
Aseptic technique reduces microbial and particulate contamination when a peptide solution will be used in cell culture or other sensitive applications. Work in a clean area, use sterile containers and filtered tips, and avoid touching vial interiors. Preparing aliquots immediately after dissolution limits repeated temperature cycling, which is a common cause of aggregation and activity loss. Low-binding plastic tubes are preferred for peptides that adsorb to surfaces, especially hydrophobic or positively charged sequences. Labels should record identity, solvent, concentration, and preparation date so that later use can be traced.
Shipping and short-term transfer require attention to temperature control and physical stability. Frozen solutions are commonly sent on dry ice, while lyophilized powders may travel with gel packs or insulated packaging. Thawing should be done slowly on ice or in a refrigerator, not by vigorous heating, and the solution should be mixed gently before use. Temperature loggers can document excursions during transit, but their presence does not prove that a peptide remained stable. Analytical checks such as chromatography or mass spectrometry can verify identity and purity after storage or shipping.
Quality control links handling to measurable identity and purity. Reverse-phase high-performance liquid chromatography can separate peptide variants and reveal impurities. Mass spectrometry confirms molecular mass and can detect truncations or modifications. These methods are often paired with ultraviolet absorbance or amino acid analysis for concentration. Documentation of instrument settings, column type, and reference standards supports reproducibility. For research materials, acceptance criteria depend on the intended application, and no universal purity threshold applies to all peptides.
Handling begins when a peptide container is opened. Hygroscopic solids can absorb atmospheric water rapidly, so bench work should be brief and containers resealed with fresh desiccant. Weighing or transferring should occur in a low-humidity environment where possible. Static electricity may cause fine powders to cling to surfaces, leading to inaccurate mass measurements. Tools such as antistatic devices or grounded workstations reduce that problem. Good laboratory practice also includes labeling date, lot, and storage condition after each opening.
Adversarial robustness is often associated with security. Researchers demonstrated that an audio signal could be imperceptibly modified so that speech-to-text systems transcribe it to any message the attacker chooses. Network intrusion and malware detection systems also must be adversarially robust since attackers may design their attacks to fool detectors. Models that represent objectives (reward models) must also be adversarially robust. For example, a reward model might estimate how helpful a text response is and a language model might be trained to maximize this score. Researchers have shown that if a language model is trained for long enough, it will leverage the vulnerabilities of the reward model to achieve a better score and perform worse on the intended task. This issue can be addressed by improving the adversarial robustness of the reward model. More generally, any AI system used to evaluate another AI system must be adversarially robust. This could include monitoring tools, since they could also potentially be tampered with to produce a higher reward. Large language models (LLMs) can be vulnerable to prompt injection and model stealing, and may be used to generate misinformation. Prompt injection involves embedding instructions into prompts in order to bypass safety measures. Some approaches against prompt injection use customizable policies and rules to analyze inputs and outputs, ensuring that potentially problematic interactions are filtered or mitigated.
This process allows many recombinant proteins to be secreted as soluble, physiologically active forms into the culture medium. The technology required for genetic manipulation of Komagataella is similar to that of Saccharomyces cerevisiae, which is one of the most well-studied yeast model organisms. As a result, the experiment protocol and materials are easy to build for Komagataella.
== Environmental impact and regulation == PFBA is a breakdown product of other PFAS that have been used in stain-resistant fabrics, paper food packaging, carpets, and consumer products. PFBA has been frequently found in U.S. rivers. In laboratory animal studies, exposure to high levels of PFBA results in thyroid and liver effects, such as increased thyroid and liver weight, changes in thyroid hormones, decreased cholesterol, and cellular changes in both organs. Other effects of PFBA exposure included delayed development and decreased red blood cells and hemoglobin. The Minnesota Department of Health (MDH) developed a guidance value of 7 ppb (μg/L) for PFBA in drinking water.
=== 2011 Sinaloa massacre === On 23 November 2011, a total of 26 bodies—16 of them burned to death—were located in several abandoned vehicles in Sinaloa. The incident began at early hours of the morning in Culiacán, Sinaloa with the discovery of a vehicle on fire. When the police forces managed to put down the flames, they found inside the vehicle a dozen bodies burned to death, and with wood remains on top of them. All of the victims were handcuffed. Later, at 07:00, anonymous calls from civilians notified the police that another vehicle in the northern city limits of Culiacán was on fire. The vehicle on fire was a Ford Ranger, and inside were four bodies with bulletproof vests and handcuffed. During the night, 10 more bodies were found throughout several municipalities. The killings were allegedly carried out by Los Zetas as a response to the massacres done by the Matazetas (CJNG) in Veracruz. Stratfor believes that this major move by Los Zetas into the territory of the Sinaloa Cartel demonstrates the Zeta's ability to attack the "heart of those cartels' territories."
==== Gel-based Proteomic Methods ==== Two-dimensional Polyacrylamide Electrophoresis (2D-PAGE) gels historically compared intensities from protease treated and untreated sample spots in order to identify possible candidate substrates. A more recent improvement of this technique, fluorescent 2D difference gel electrophoresis (2D-DIGE), attempts to control standardization between gels for relative quantification. Differentially labelling protease-treated and untreated samples with either Cy3 or Cy5, pooling said samples, and analyzing them together by 2D-PAGE allows substrate and cleavage products to be studied from the fluorescent gel. The spots corresponding to potentially substrate and cleavage products can be later elucidated using Mass Spectrometry or Edman Sequencing. The biggest drawbacks to using these techniques relate to the chemistry of the technique itself and its lack of sensitivity. As they rely on PAGE gels, extremely large, small, highly hydrophobic, acidic, or basic molecules will not be visualized.
Sources: en.wikipedia.org
== Side effects == Gastrointestinal tract: Ulceration and possible rupture of the esophagus; this may require hospitalization and intensive treatment. Gastric and duodenal ulceration may also occur. Esophageal cancer, a meta-analysis concluded that bisphosphonate treatment is not associated with excess risk of esophageal cancer. General: infrequent cases of skin rash, rarely manifesting as Stevens–Johnson syndrome and toxic epidermal necrolysis, eye problems (uveitis, scleritis) and generalized muscle, joint, and bone pain (rarely severe) have been reported. Osteonecrosis of the jaw (ONJ) may occur while on this drug, if dental work of any kind is carried out. The risk is considerably higher for extractions in the mandible (lower jaw) than other areas of the mouth, and the risk increases if you have been taking it for four or more years Although this side effect is uncommon (0.4-1.6% for oral alendronic acid), it occurs primarily in patients being administered intravenous bisphosphonates, with most cases being reported in cancer patients.
Neanderthals ( nee-AN-də(r)-TAHL, nay-, -THAHL; Homo neanderthalensis or sometimes Homo sapiens neanderthalensis) are an extinct group of archaic humans who inhabited Europe and Western and Central Asia during the Middle to Late Pleistocene. Neanderthal extinction occurred roughly 40,000 years ago with the immigration of modern humans (Cro-Magnons), but Neanderthals in Gibraltar may have persisted for thousands of years longer. The first recognised Neanderthal fossil, Neanderthal 1, was discovered in 1856 in the Neander Valley, Germany. At first, Neanderthal 1 was considered to be one of the lower races in accord with historical race concepts. As more fossils were discovered through the early 20th century, Neanderthals were characterised as a unique species of underdeveloped human, in particular by Marcellin Boule. By the mid-twentieth century, it was believed that human evolution progressed from an ape-like ancestor through a "Neanderthal phase" to modern humans. This gave way to the "Out of Africa" theory in the 1970s. Sequencing of the Neanderthal genome in 2010 revealed that Neanderthals interbred with modern humans. Neanderthal anatomy is characterised by a long and low skull, a heavy and rounded brow ridge (supraorbital torus), an occipital bun (bony projection) at the back of the skull, strong teeth and jaws, a wide chest, and short limbs. These traits gradually became more frequent through the Middle Pleistocene of Europe, possibly due to natural selection in a cold climate, as well as genetic drift when populations collapsed during glacial periods.
Balance of power systems have in the past tended, through the process of conquest of lesser states by greater states, towards reduction in the number of states involved, and towards less frequent but more devastating wars, until eventually a universal empire has been established through the conquest by one of all those remaining. The post-Cold War period represents an anomaly to the balance of power theory too. Rousseau defined the theoretical limit how far balance of power can be altered: "Will it be supposed that two or three potentates might enter into an agreement to subdue the rest? Be it so. These three potentates, whoever they may be, will not possess half the power of all Europe." In 2009, Stephen Walt observed, "Within two-and-a-half centuries, only one potentate possessed half the power of all the world, including Europe. In 2008, US military expenditures, including supplemental spending, exceeded those of the rest of the world combined." Since 2000, the founder of Neorealism, Kenneth Waltz, confessed that "the present condition of international politics is unnatural." "Clearly something has changed." Wohlforth, Little and Kaufman undertook the above-mentioned historical study after they had coped with what they called the "puzzle" of the unipolar stability. Elsewhere, Richard Little wrote: Events since the end of the Cold War "create a potential anomaly" for the theory because the outcome has "left the United States as the sole superpower in a unipolar world ... A major puzzle for realists ...
=== Side effects === Reactogenicity is similar to that of conventional, non-RNA vaccines. However, those susceptible to an autoimmune response may have an adverse reaction to mRNA vaccines. The mRNA strands in the vaccine may elicit an unintended immune reaction – this entails the body believing itself to be sick, and the person feeling as if they are as a result. To minimize this, mRNA sequences in mRNA vaccines are designed to mimic those produced by host cells. Strong but transient reactogenic effects were reported in trials of novel COVID-19 mRNA vaccines; most people will not experience severe side effects which include fever and fatigue. Severe side effects are defined as those that prevent daily activity.
Sources: en.wikipedia.org
In 1996, the FDA removed all restrictions from aspartame, allowing it to be used in all foods. As of May 2023, the FDA stated that it regards aspartame as a safe food ingredient when consumed within the acceptable daily intake level of 50 mg per kg of body weight per day. Several European Union countries approved aspartame in the 1980s, with EU-wide approval in 1994. The Scientific Committee on Food (SCF) reviewed subsequent safety studies and reaffirmed the approval in 2002. The European Food Safety Authority (EFSA) reported in 2006 that the previously established acceptable daily intake (ADI) was appropriate, after reviewing yet another set of studies.
Polyhistidine tags most commonly consist of six histidine residues. Tags with up to twelve histidine residues or dual tags attached via short linker are not uncommon though and may improve purification results by enhancing binding to the affinity resin, allowing for increased stringency of washing and separation from endogenous proteins. The tag can be added to a gene of interest using methods common to most purification tags. The most basic method is to subclone the gene of interest into a vector containing a polyhistidine tag sequence. Many vectors for use with various expression systems are available with polyhistidine tags in a variety of positions and with differing protease cleavage sites, other tags etc. However, if an appropriate vector is unavailable or the tag needs to be inserted at a location other than the proteins N- or C-terminus, the gene of interest can be either directly synthesised containing a polyhistidine tag sequence or various methods based on PCR can be used to add the tag to a gene. A common approach is to add the coding sequence for the polyhistidine tag to the PCR primers as an overhang.
Relaxin is a protein hormone of about 6000 Da, first described in 1926 by Frederick Hisaw. The relaxin family peptide hormones belong to the insulin superfamily and consists of seven peptides of high structural but low sequence similarity; relaxin-1 (RLN1), 2 (RLN2) and 3 (RLN3), and the insulin-like (INSL) peptides, INSL3, INSL4, INSL5 and INSL6. The functions of relaxin-3, INSL4, INSL5, and INSL6 remain uncharacterised.
Among the 16 genes, the analysis identified two for which rare mutations are known to cause monogenic obesity: MC4R and PCSK1 (proprotein convertase subtilisin/kexin type 1). One study provides genetic evidence linking rare coding variation to BMI and obesity-related phenotypes. MC4R gene mutations are associated with early-onset severe obesity. The effect of two exemplary heterozygous coding variants in the MC4R gene (C293R and S94N) are: • Rapid weight gains from early age (the most important feature). • Development of severe obesity (BMI ≫97th percentile) at early ages, usually <3 years of age. • Persistent food-seeking behavior, mostly reported from six months of age. • Parental/siblings anthropometric data: suspect if relatives present normal anthropometric data. • Tall stature/increased growth velocity (MC4R monogenic diabetes). There is limited treatment options for the most common form of monogenic obesity, MC4R mutations symptoms can be treated with a Glucagon-like Peptide-1 Receptor Agonist liraglutide which cause weight loss by reducing appetite. They found that the effects of liraglutide 3.0 mg daily for 16 weeks causes weight reducing and glucose lowering and may be relevant treatment in the most common form of monogenic obesity.
=== Addiction === NF-κB is one of several induced transcriptional targets of ΔFosB which facilitates the development and maintenance of an addiction to a stimulus. In the caudate putamen, NF-κB induction is associated with increases in locomotion, whereas in the nucleus accumbens, NF-κB induction enhances the positive reinforcing effect of a drug through reward sensitization.
Sources: en.wikipedia.org
Peptide degradation can arise from hydrolysis, oxidation, deamidation, and aggregation. The dominant route depends on the peptide sequence and the storage environment. Temperature, moisture, oxygen, light, and pH all influence the rate.
Freezing slows many chemical reactions but does not stop all degradation. Repeated freeze-thaw cycles can promote aggregation or precipitation. Dry powders and solutions may respond differently to freezing.
pH affects the charge state of ionizable groups and can influence deamidation, hydrolysis, and aggregation. A pH that stabilizes one peptide may destabilize another. Buffer components can also participate in degradation or stabilization.
Common solvents include sterile water, phosphate-buffered saline, and water-acetonitrile mixtures. The choice depends on the peptide's solubility profile and the buffer compatibility for the intended application. Manufacturers often provide a recommended solvent on the product information sheet.